Literature DB >> 19222089

Pediatric liver transplantation.

Marco Spada1, Silvia Riva, Giuseppe Maggiore, Davide Cintorino, Bruno Gridelli.   

Abstract

In previous decades, pediatric liver transplantation has become a state-of-the-art operation with excellent success and limited mortality. Graft and patient survival have continued to improve as a result of improvements in medical, surgical and anesthetic management, organ availability, immunosuppression, and identification and treatment of postoperative complications. The utilization of split-liver grafts and living-related donors has provided more organs for pediatric patients. Newer immunosuppression regimens, including induction therapy, have had a significant impact on graft and patient survival. Future developments of pediatric liver transplantation will deal with long-term follow-up, with prevention of immunosuppression-related complications and promotion of as normal growth as possible. This review describes the state-of-the-art in pediatric liver transplantation.

Entities:  

Mesh:

Year:  2009        PMID: 19222089      PMCID: PMC2653434          DOI: 10.3748/wjg.15.648

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  206 in total

1.  Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An International Panel.

Authors:  A Demetris; D Adams; C Bellamy; K Blakolmer; A Clouston; A P Dhillon; J Fung; A Gouw; B Gustafsson; H Haga; D Harrison; J Hart; S Hubscher; R Jaffe; U Khettry; C Lassman; K Lewin; O Martinez; Y Nakazawa; D Neil; O Pappo; M Parizhskaya; P Randhawa; S Rasoul-Rockenschaub; F Reinholt; M Reynes; M Robert; A Tsamandas; I Wanless; R Wiesner; A Wernerson; F Wrba; J Wyatt; H Yamabe
Journal:  Hepatology       Date:  2000-03       Impact factor: 17.425

2.  The safety and efficacy of a two-dose daclizumab (zenapax) induction therapy in liver transplant recipients.

Authors:  D E Eckhoff; B McGuire; M Sellers; J Contreras; L Frenette; C Young; S Hudson; J S Bynon
Journal:  Transplantation       Date:  2000-05-15       Impact factor: 4.939

3.  Therapeutic drug monitoring of sirolimus: correlations with efficacy and toxicity.

Authors:  B D Kahan; K L Napoli; P A Kelly; J Podbielski; I Hussein; D L Urbauer; S H Katz; C T Van Buren
Journal:  Clin Transplant       Date:  2000-04       Impact factor: 2.863

4.  Comparative long-term evaluation of tacrolimus and cyclosporine in pediatric liver transplantation.

Authors:  A Jain; G Mazariegos; R Kashyap; M Green; C Gronsky; T E Starzl; J Fung; J Reyes
Journal:  Transplantation       Date:  2000-08-27       Impact factor: 4.939

5.  Predictors of survival after In vivo split liver transplantation: analysis of 110 consecutive patients.

Authors:  R M Ghobrial; H Yersiz; D G Farmer; F Amersi; J Goss; P Chen; S Dawson; S Lerner; N Nissen; D Imagawa; S Colquhoun; W Arnout; S V McDiarmid; R W Busuttil
Journal:  Ann Surg       Date:  2000-09       Impact factor: 12.969

6.  Extensive use of split liver for pediatric liver transplantation: a single-center experience.

Authors:  M Spada; B Gridelli; M Colledan; A Segalin; A Lucianetti; W Petz; S Riva; G Torre
Journal:  Liver Transpl       Date:  2000-07       Impact factor: 5.799

7.  The effect of immunosuppression on posttransplant lymphoproliferative disease in pediatric liver transplant patients.

Authors:  B S Younes; S V McDiarmid; M G Martin; J H Vargas; J A Goss; R W Busuttil; M E Ament
Journal:  Transplantation       Date:  2000-07-15       Impact factor: 4.939

8.  Normalised intrinsic mortality risk in liver transplantation: European Liver Transplant Registry study.

Authors:  R Adam; V Cailliez; P Majno; V Karam; P McMaster; R Y Caine; J O'Grady; R Pichlmayr; P Neuhaus; J B Otte; K Hoeckerstedt; H Bismuth
Journal:  Lancet       Date:  2000-08-19       Impact factor: 79.321

Review 9.  Steroid withdrawal in liver transplantation: benefits, risks, and unanswered questions.

Authors:  R Reding
Journal:  Transplantation       Date:  2000-08-15       Impact factor: 4.939

Review 10.  Post-transplant malignancy: the role of immunosuppression.

Authors:  I Penn
Journal:  Drug Saf       Date:  2000-08       Impact factor: 5.228

View more
  29 in total

1.  Pediatric Liver Transplantation: Our Experiences.

Authors:  Ahmet Basturk; Aygen Yılmaz; Ersin Sayar; Ayhan Dinçkan; İbrahim Aliosmanoğlu; Halil Erbiş; Bülent Aydınlı; Reha Artan
Journal:  Eurasian J Med       Date:  2016-10

Review 2.  Psychiatric issues in pediatric organ transplantation.

Authors:  Margaret L Stuber
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2010-04

Review 3.  Pathobiology of inherited biliary diseases: a roadmap to understand acquired liver diseases.

Authors:  Luca Fabris; Romina Fiorotto; Carlo Spirli; Massimiliano Cadamuro; Valeria Mariotti; Maria J Perugorria; Jesus M Banales; Mario Strazzabosco
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-08       Impact factor: 46.802

Review 4.  Undiagnosed liver diseases.

Authors:  Emily Gao; Julian Hercun; Theo Heller; Sílvia Vilarinho
Journal:  Transl Gastroenterol Hepatol       Date:  2021-04-05

5.  Calcineurin inhibitors dampen humoral immunity by acting directly on naive B cells.

Authors:  R De Bruyne; D Bogaert; N De Ruyck; B N Lambrecht; M Van Winckel; P Gevaert; M Dullaers
Journal:  Clin Exp Immunol       Date:  2015-06       Impact factor: 4.330

Review 6.  Coagulopathy and transfusion therapy in pediatric liver transplantation.

Authors:  Mirco Nacoti; Davide Corbella; Francesco Fazzi; Francesca Rapido; Ezio Bonanomi
Journal:  World J Gastroenterol       Date:  2016-02-14       Impact factor: 5.742

Review 7.  Current developments in pediatric liver transplantation.

Authors:  Christina Hackl; Hans J Schlitt; Michael Melter; Birgit Knoppke; Martin Loss
Journal:  World J Hepatol       Date:  2015-06-18

8.  [Living donation liver transplantation in children].

Authors:  B Dresske; M Schulze; F Braun; J Walter; M Kohl; S Schulz-Jürgensen; M Krause; M Schrappe; M Burdelski; D C Bröring
Journal:  Chirurg       Date:  2010-09       Impact factor: 0.955

9.  Cytomegalovirus Infection in Pediatric Solid Organ Transplant Recipients: a Focus on Prevention.

Authors:  Karen C Tsai; Lara A Danziger-Isakov; David B Banach
Journal:  Curr Infect Dis Rep       Date:  2016-01       Impact factor: 3.725

10.  Pediatric liver transplantation: predictors of survival and resource utilization.

Authors:  Amy E Wagenaar; Jun Tashiro; Juan E Sola; Obi Ekwenna; Akin Tekin; Eduardo A Perez
Journal:  Pediatr Surg Int       Date:  2016-03-21       Impact factor: 1.827

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.